Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of NC762 in patients with advanced or metastatic solid tumors has been terminated, with results po…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics [Phase 1]
A Phase 1 trial evaluating ribociclib plus belinostat for metastatic triple-negative breast cancer and recurrent ovarian cancer, with genomi…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy [Phase 2]
Phase 2 trial evaluating SBRT alone or followed by Niraparib for recurrent ovarian cancer with oligometastases or oligoprogression after PAR…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
A completed clinical trial update reports that OC Detect improves early diagnosis for ovarian and endometrial cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma [Phase 2]
This Phase 2 trial of autologous tumor-infiltrating lymphocytes (MDA-TIL) in recurrent or refractory ovarian cancer, colorectal cancer, and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer [Phase 3]
This update notes a Phase 3 trial evaluating relacorilant in combination with nab-paclitaxel for advanced platinum-resistant ovarian, primar…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating AK112 in combination with chemotherapy and/or Olaparib for platinum-sensitive ovarian cancer; recruitment …
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Ongoing University of Alberta-sponsored LONGEVITI study, LIVInG With chrONic Cancer TrEatments, is currently recruiting to evaluate cancer t…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer
Clinical trial exploring an exosome-based recurrence score for post-treatment ovarian cancer; recruitment has not yet begun.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 study comparing IBI354 to investigator's choice chemotherapy in platinum-resistant ovarian, primary peritoneal, or fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel [Phase 1]
Phase 1 study evaluating the safety and tolerability of a PARP inhibitor in combination with carboplatin and/or paclitaxel in patients with …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1 [Phase 1]
Phase 1 study evaluating the molecular imaging agent [123I]I-DARPIN-Ec1 targeting EpCAM receptors in lung cancer and ovarian cancer has comp…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
A completed clinical trial update on using new molecular markers to guide personalized therapy for ovarian cancer (the MEMENTO study).
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer [Phase 3]
This document reports a completed Phase 3 trial comparing atezolizumab with bevacizumab and chemotherapy versus bevacizumab and chemotherapy…
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi [Phase 2]
A Phase 2 trial evaluating dostarlimab plus niraparib for relapsed ovarian, fallopian tube, or primary peritoneal cancer has been withdrawn.…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating vaccine therapy using sargramostim (GM-CSF) in patients with HER2-positive stage III-IV breast cancer or o…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update for Mirvetuximab soravtansine (IMGN853) in FRα-high recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Diagnosing Ovarian Cysts - the DOC Study
Completed clinical trial from Rigshospitalet, Denmark, the DOC Study, evaluating diagnostic methods for ovarian cysts and their ability to d…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]
A Phase 2 study of seribantumab in adults with NRG1 gene fusion-positive advanced solid tumors has been terminated, with results posted in A…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors
A completed clinical trial update examining metabolite levels in ovarian cancer patients receiving maintenance PARP inhibitors.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TT-10 and TT-4 (Portage Biotech) exploring single-agent and combination therapy in advanced solid tumors, with rec…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
A clinical trial at University Hospital Strasbourg is evaluating whether a paradigm shift in the therapeutic strategy improves survival for …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of TCR-like CAR-T cells targeting mesothelin in ovarian cancer; the trial is currently active bu…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors [NA]
Phase I clinical trial evaluating CAR-T cell therapy for advanced gynecologic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer) [NA]
Clinical trial update for the BICOV-1 study evaluating bidirectional intraperitoneal chemotherapy after optimal interval surgery in advanced…